Introduction {#ss1}
============

Historically, the prevalence of type 2 diabetes was low in Japan when compared with the USA. However, reports that diabetes prevalence is higher in Japanese Americans than in white Americans suggest that Japanese are not necessarily protected from developing hyperglycemia. Sloan reported in 1963 that the age‐adjusted rate for diabetes (per 1,000 person years) in Hawaii was 20.1 for Japanese and 7.3 in Caucasians[^1^](#b1){ref-type="ref"}. This showed that Japanese might be inherently at risk of developing diabetes and that this is manifest on exposure to factors related to living in the USA. This possibility was further supported by research showing higher rates of abnormal glucose tolerance among Japanese Americans in Hawaii and California than in native Japanese[^2,3^](#b2 b3){ref-type="ref"}.

West described, in a seminal paper that appeared in 1974, the epidemic of diabetes among Native Americans who had previously not experienced much diabetes[^4^](#b4){ref-type="ref"}. He wrote that environmental factors were exerting powerful influences and that obesity was a significant risk factor. Obesity, through its strong association with insulin resistance, is now widely accepted to significantly increase the risk for type 2 diabetes[^5,6^](#b5 b6){ref-type="ref"}. However, Japanese Americans, who like many other Asians had a body mass index (BMI) on average lower than of other populations, are still at risk of developing obesity‐related diseases[^7^](#b7){ref-type="ref"}.

A pilot study was begun in 1979 and completed in 1981 to compare body size among diabetic Japanese American and Caucasian men in Seattle, and diabetic native Japanese men in Tokyo[^8,9^](#b8 b9){ref-type="ref"}. Japanese Americans were not as heavy as Caucasians, but were heavier on average than native Japanese. Dietary patterns were examined using 1‐day dietary recall interviews or 3‐day diet records. Daily kilocalories consumed by Japanese Americans and native Japanese were similar and less than consumed by Caucasians, but Japanese Americans took in much more total fat and less carbohydrate than native Japanese. The proportion of food consumed as fat was similar between Japanese Americans and Caucasians[^8,9^](#b8 b9){ref-type="ref"}. Thus, the diet pattern of Japanese Americans was closer to the Western diet than the Japanese diet, suggesting that one component of a 'Westernized' lifestyle -- higher consumption of dietary fat -- was followed by Japanese Americans and might play a role in their development of obesity and diabetes.

Because of these preliminary findings, the Seattle Japanese American Community Diabetes Study was begun to learn more about the interaction of 'nature' and 'nurture' in the development of type 2 diabetes in Japanese Americans ([Figure 1](#f1){ref-type="fig"}). In the present review, we cover many of our key observations.

![ The overarching hypothesis for the Seattle Japanese American Community Diabetes Study was that nature and nurture interacted in the development of type 2 diabetes.](jdi-3-212-g1){#f1}

Seattle Japanese American Community Diabetes Study: Background and Design {#ss2}
=========================================================================

When we first became interested in the study of diabetes in Japanese Americans, they were the third largest Asian ethnic group in the USA, after Chinese and Filipino[^10^](#b10){ref-type="ref"}. Because of lower Japanese immigration to the USA compared with other Asian ethnicities, Japanese Americans now rank as the sixth largest Asian population after Chinese, Filipino, Asian Indians, Vietnamese and Koreans[^10,11^](#b10 b11){ref-type="ref"}. Most Japanese Americans belong to families that have a long history of being in the USA, an attractive characteristic for examining the influence of lifestyle factors in the development of type 2 diabetes.

The original immigrants from Japan to the USA arrived during a discrete and relatively short interval from the late 1800s until passage of the Immigration Act of 1924 stopped further immigration from Asia. This prohibition resulted in the isolation of Japanese couples in the USA to create a discrete, well‐defined immigrant generation that produced two fairly discrete succeeding generations. The first immigrant generation is called 'Issei' (first generation), with their children born in the USA being 'Nisei' (second generation) and their grandchildren being 'Sansei' (third generation). The Japanese American Community Diabetes Study included only individuals of pure Japanese ancestry residing in King County, Washington, who were Nisei or Sansei. This Japanese American population had already been exceptionally well characterized[^12^](#b12){ref-type="ref"}.

Recruitment began in 1983 with a volunteer sample of Nisei men (*n* = 229). The study sample was expanded in 1986 to include Nisei women (*n* = 191) and Sansei men (*n* =120) and women (*n* = 118)[^13--15^](#b13 b14 b15){ref-type="ref"}. As education in the USA is an important aspect of the Nisei life experience, American‐born Nisei who returned to Japan for their education were excluded. Nisei participants were selected to oversample diabetic individuals in order to compare diabetic with non‐diabetic individuals. Oversampling of diabetic individuals was not carried out for Sansei. Because of the large number of individuals with impaired glucose tolerance (IGT), impaired fasting glucose (IFG) or both found among the non‐diabetic participants, this sampling protocol also made it possible to compare persons with normal glucose tolerance (NGT), IFG, IGT, IFG/IGT and diabetes. Finally, although the study participants were volunteers, they were shown to be very similar in terms of several demographic characteristics to the overall Japanese American population of King County, Washington[^13,14^](#b13 b14){ref-type="ref"}.

The protocol for the present study was reviewed and approved by the Human Subjects Review Committee at the University of Washington, and signed informed consent was received from all participants. Baseline examinations were carried out from 1983 to 1986 for Nisei men, from 1986 to 1988 for Nisei women, and from 1988 to 1991 for all Sansei. In this prospective cohort study, participants were followed for 10 years with overall return rates of 72.9% for Nisei men, 72.3% for Nisei women, 80.8% for Sansei men and 80.5% for Sansei women. Among the large amount of baseline information obtained on each participant was information regarding lifestyle (diet, physical activity); blood pressure; bodyweight, height and BMI; anthropometry (waist and hip circumference, skinfold thickness); fasting lipids (cholesterol, low‐density lipoprotein \[LDL\] cholesterol, high‐density lipoprotein \[HDL\] cholesterol and triglycerides); glucose, insulin and C‐peptide at 0‐, 30‐, 60‐, 90‐ and 120‐min of a 75‐g oral glucose tolerance test (OGTT); and body fat areas measured by computed tomography (CT) with single slice scans of the thorax (nipples), abdomen (umbilicus) and thigh (mid‐thigh) to measure subcutaneous fat areas and, in the abdominal scan, visceral fat area. Measurements were repeated at follow‐up examinations scheduled at 5 and 10 years (a 2.5‐year follow‐up examination was also carried out in Nisei men).

Diabetes, Body Fat and Lifestyle in Nisei: Early Findings in Nisei Men {#ss3}
======================================================================

We estimated the prevalence of diabetes in Nisei men and women in the study population to be 20 and 16%, respectively[^13,14^](#b13 b14){ref-type="ref"}. In contrast, published prevalence rates of diabetes in Tokyo were 5% in men and 4% in women[^16^](#b16){ref-type="ref"}. Also notable was that the prevalence of diabetes in Nisei was higher than in the adult USA population.

The earliest clues to the etiopathogenesis of type 2 diabetes in Japanese Americans came from the Nisei men with whom we began the present research. In order to learn more about possible differences in pathophysiology of diabetes between Nisei and Japanese, we compared Nisei diabetic men with diabetic men in Tokyo[^17^](#b17){ref-type="ref"}. Both groups had similar mean ages and showed no significant difference in glucose levels during a 3‐h 75‐g OGTT ([Figure 2](#f2){ref-type="fig"}). However, Nisei men had much higher insulin levels ([Figure 3](#f3){ref-type="fig"}). Tokyo men all had diabetes duration of ≥2 years, whereas many Nisei had a shorter duration of diabetes, but a comparison of insulin levels with Nisei men having diabetes duration of ≥2 years still showed significantly higher insulin in Nisei. Thus, Nisei were very insulin resistant when compared with Tokyo men. Nisei men and Tokyo men had similar mean ages, but the former were heavier -- mean BMI 25.7 kg/m^2^ in Nisei vs 21.8 kg/m^2^ in native Japanese -- and insulin levels were significantly and positively correlated with BMI in Nisei. After adjustment for BMI, only the fasting insulin levels remained significantly different between Nisei and native Japanese, suggesting that factors other than body size also played a role in the greater insulin resistance in Nisei.

![ Mean blood glucose levels with 3‐h oral glucose tolerance test were not significantly different between diabetic men in Tokyo (*n* = 26) and Seattle (*n* = 68).](jdi-3-212-g2){#f2}

![ Mean plasma insulin levels with 3‐h oral glucose tolerance test were significantly higher (*P* \< 0.006) in diabetic men in Seattle (*n* = 68) than in Tokyo (*n* = 26). Comparison of insulin assays between Seattle and Tokyo showed an excellent correlation (*r* = 0.885, *P* \< 0.001) with Seattle levels tending to be slightly, but not significantly, lower than in Tokyo.](jdi-3-212-g3){#f3}

In addition to total body fat, body shape is also an important factor related to diabetes prevalence. After Vague[^18^](#b18){ref-type="ref"} reported that diseases such as diabetes are associated with body shape, the latter has been usually assessed by anthropometry; for example, measuring waist and hip circumference and skinfold thickness at several body surface sites. To distinguish central adiposity into visceral and subcutaneous adiposity, we also chose to use CT scans to examine body fat distribution by measuring subcutaneous fat areas in the chest and thigh, and both subcutaneous and visceral fat areas in the abdomen[^19--21^](#b19 b20 b21){ref-type="ref"}. Soon after we began using this technique, we found that diabetic Nisei men tended to have more intra‐abdominal fat than Nisei men with NGT ([Figure 4](#f4){ref-type="fig"})[^22^](#b22){ref-type="ref"}. A more extensive analysis of the baseline data in Nisei men that included measurements of general fatness as well as site‐specific fat deposition (BMI, subcutaneous skinfold thickness and CT) clearly identified the diabetes group as possessing disproportionately larger amounts of central fat compared with the IGT and NGT groups, whereas increased intra‐abdominal fat accompanied both IGT and diabetes[^23^](#b23){ref-type="ref"}.

![ Diabetic Nisei men tended to have greater intra‐abdominal fat area by computed tomography (CT) than normal glucose tolerance (NGT) Nisei men. Two representative abdominal CT scans with low and high intra‐abdominal fat areas are shown at the bottom with intra‐abdominal fat colored white.](jdi-3-212-g4){#f4}

Diet was clearly a lifestyle‐related risk factor for diabetes in the Nisei men. Nisei men with type 2 diabetes consumed greater amounts of both total and animal fat and animal protein, less carbohydrate, and similar total kilocalories compared with non‐diabetic Nisei men[^24^](#b24){ref-type="ref"}. Among men who entered the study without a prior history of diabetes, but who were found to have diabetes at the time of their baseline OGTT, there was increased intake of animal fat and protein, but not lower consumption of carbohydrate. The difference between men with previously diagnosed and undiagnosed diabetes was because the latter did not curtail intake of refined carbohydrate like those who already had a history of diabetes, showing that this behavior might be a conscious, self‐imposed change in response to their disease. These results suggested that increased consumption of animal fat and protein might be an important diabetes risk factor in Japanese Americans.

In a prospective analysis of Nisei men who had IGT at baseline, both dietary animal fat and animal protein intake at baseline were significantly correlated with 2‐h glucose levels during an OGTT at 5 years of follow up and also related to future diabetes[^25^](#b25){ref-type="ref"}. Furthermore, baseline energy expenditure (physical activity) tended to be lower in those men who had higher glucose levels at 5 years. Interestingly, these detrimental effects were especially true for those with a positive family history of diabetes; that is, those who might already have a hereditary predisposition ([Figure 5](#f5){ref-type="fig"}). In contrast, cross‐sectional data in Nisei men showed that diabetes was associated with increased BMI, waist circumference and intra‐abdominal fat only among those without a family history of diabetes[^26^](#b26){ref-type="ref"}. As diabetes risk related to adiposity is presumably through insulin resistance, this suggested that the risk imposed by family history was more strongly attributable to other factors related to glucose metabolism; for example, β‐cell function.

![ The mean 2‐h plasma glucose levels at 5 years of follow up in Nisei men who were impaired glucose tolerance at baseline were progressively higher as level of risk increased and were higher in those with a family history (hx) of diabetes. The trend with level of risk was significant (*P* \< 0.05) in those with a family history of diabetes. Low risk: low dietary animal fat and protein plus high physical activity; intermediate risk: low dietary animal fat and protein and low physical activity or high dietary animal fat and protein and high physical activity; high risk: high dietary animal fat and protein and low physical activity.](jdi-3-212-g5){#f5}

Similar observations have come from Brazil, home of the largest Japanese population outside Japan. Japanese migration to Brazil increased markedly after immigration to the USA stopped in 1924 and continued until the start of the Second World War. The Japanese‐Brazilian population is therefore younger than their Japanese American counterparts. Consequently, a study carried out in the city of Bauru, Sao Paulo, included a substantial number of Issei, as well as Nisei and Sansei. This population had a high risk for type 2 diabetes, hypertension and dyslipidemia[^27^](#b27){ref-type="ref"}. Whether born in Japan or in Brazil, the intake of energy from fat (approximately 32%) by Japanese Brazilians was substantially increased when compared with the usual intake reported in Japan (approximately 25%)[^28^](#b28){ref-type="ref"}. In addition, the prevalence of BMI ≥ 30 kg/m^2^ was 7.5%, much higher than in Japan[^29,30^](#b29 b30){ref-type="ref"}. Notably, those Japanese Brazilians who had BMI ≥ 25.0 kg/m^2^ or central adiposity (waist circumference \>80 cm for women and \>90 cm for men) consumed higher proportions of energy as fat and lower proportions of energy as carbohydrate than those with BMI \< 25.0 kg/m^2^ and without central adiposity[^31^](#b31){ref-type="ref"}.

Importance of Body Fat Distribution as a Risk Factor: Further Studies {#ss4}
=====================================================================

After showing that visceral adiposity was associated with prevalent diabetes, we found an association of visceral adiposity with prevalent coronary heart disease[^32^](#b32){ref-type="ref"}, hypertension[^33,34^](#b33 b34){ref-type="ref"} and dyslipidemia[^35^](#b35){ref-type="ref"}. In prospective analyses, intra‐abdominal fat at baseline was more closely associated with incident diabetes than were baseline BMI, waist circumference or skinfold thickness at as early as 2.5 years of follow up in Nisei men[^36^](#b36){ref-type="ref"}. These incident cases also had higher fasting C‐peptide levels and lower 30‐min insulin responses after oral glucose (incremental insulin response). In subsequent longer 10‐year follow‐up studies, we found that increased amounts of intra‐abdominal fat at baseline were independently related to incident coronary heart disease in Nisei men[^37^](#b37){ref-type="ref"} and to incident hypertension[^38^](#b38){ref-type="ref"}, impaired glucose tolerance[^39^](#b39){ref-type="ref"}, diabetes[^40^](#b40){ref-type="ref"} and metabolic syndrome[^41^](#b41){ref-type="ref"} in Nisei and Sansei men and women. Regarding incident diabetes, baseline data and the results of several multivariate models are shown in [Tables 1 and 2](#t1 t2){ref-type="table-wrap"}.

######  Characteristics of Nisei at baseline according to whether diabetes developed by the end of 10‐year follow up

  Characteristic (mean)                     Did not progress to diabetes (*n* = 211)   Progressed to diabetes (*n* = 65)   Odds ratio (95% CI)   *P*‐value
  ----------------------------------------- ------------------------------------------ ----------------------------------- --------------------- -----------
  Age (years)                               61.1                                       63.3                                1.7 (1.2--2.3)        0.003
  Family history of diabetes (%)            35                                         52                                  2.2 (1.3--3.6)        0.004
  IGT at baseline (%)                       39                                         82                                  6.5 (3.4--12.5)       \<0.001
  Fasting C‐peptide (pmol/L)                0.86                                       0.98                                1.3 (1.0--1.6)        0.022
  Incremental insulin response              46.7                                       32.4                                0.4 (0.2--0.7)        0.003
  Intra‐abdominal fat area (cm^2^)          96.5                                       115.9                               1.4 (1.1--1.8)        0.018
  Subcutaneous abdominal fat area (cm^2^)   163.1                                      160.2                               1.0 (0.8--1.3)        0.887
  Total fat area (cm^2^)                    494.1                                      500.7                               1.0 (0.8--1.4)        0.780
  BMI (kg/m^2^)                             24.1                                       24.9                                1.0 (0.8--1.4)        0.664

BMI, body mass index; CI, confidence interval; IGT, impaired glucose tolerance.

######  Multivariate models of incident diabetes in Nisei (adjusted for age, female sex, impaired glucose tolerance at baseline, family history, fasting C‐peptide and incremental insulin response)

  Model                             Variables                  OR (95% CI)      *P*‐value
  --------------------------------- -------------------------- ---------------- -----------
  1                                 Intra‐abdominal fat area   1.6 (1.1--2.3)   0.019
  Non‐intra‐abdominal fat area      0.7 (0.5--1.0)             0.064            
  2                                 Intra‐abdominal fat area   1.6 (1.1--2.4)   0.023
  BMI                               0.8 (0.5--1.2)             0.251            
  3                                 Intra‐abdominal fat area   1.8 (1.1--2.8)   0.012
  Total fat area                    0.7 (0.4--1.0)             0.064            
  4                                 Intra‐abdominal fat area   1.6 (1.1--2.3)   0.013
  Subcutaneous abdominal fat area   0.7 (0.5--1.0)             0.078            

BMI, body mass index.

As a result of the importance of the visceral adipose depot as a metabolic risk factor in Japanese Americans, we examined whether visceral adiposity might be associated with greater future insulin resistance independent of other adipose depots[^42^](#b42){ref-type="ref"}. Non‐diabetic Japanese Americans were followed for 10 years and baseline variables were examined with respect to insulin resistance at 10 years. Insulin sensitivity was evaluated by the?homeostasis model assessment for insulin resistance (HOMA‐IR)[^43^](#b43){ref-type="ref"}, fasting plasma insulin, Matsuda index[^44^](#b44){ref-type="ref"} and area under the OGTT curve of insulin (AUC insulin). Because the fasting insulin level as an estimate of insulin sensitivity might be confounded by differences in β‐cell function[^45^](#b45){ref-type="ref"}, the difference between the insulin response at 30 min and fasting insulin divided by the difference between the glucose level at 30 min and fasting glucose was used to assess insulin release in all analyses of insulin sensitivity[^46^](#b46){ref-type="ref"}. Both baseline intra‐abdominal fat area and all measurements of insulin sensitivity were independently associated with increased insulin resistance at follow up, and intra‐abdominal fat remained a significant predictor of increased insulin resistance even after adjustment for total subcutaneous fat area and total fat area by CT, BMI or waist circumference ([Table 3](#t3){ref-type="table-wrap"}). Therefore, visceral fat was the most important fat depot in the relationship between obesity and insulin resistance.

######  Multiple linear regression analysis of Model 1 of homeostasis model assessment for insulin resistance at follow up

  Independent variables (baseline)    Log~e~(HOMA‐IR)   
  ----------------------------------- ----------------- ---------
  Intra‐abdominal fat area            0.0361            \<0.001
  Abdominal subcutaneous fat area\*   −0.0003           0.554
  HOMA‐IR^†^                          0.1327            \<0.001
  Incremental insulin response        0.0003            0.665
  2‐h plasma glucose                  0.0002            0.791
  Age                                 −0.0033           0.151
  Sex                                 −0.0692           0.227
  Model *R*^2^                        0.362             

\*Similar findings when total subcutaneous fat area or total fat area by computed tomography, body mass index or waist circumference was substituted for abdominal subcutaneous fat area.

^†^Similar findings when fasting insulin, Matsuda index, or area under the curve insulin was substituted for homeostasis model assessment for insulin resistance (HOMA‐IR).

We also examined over a 10‐year follow‐up interval whether increases in bodyweight and fat varied by age and sex in non‐diabetic Japanese American men and women[^47^](#b47){ref-type="ref"}. The youngest participants gained the most weight, subcutaneous abdominal fat and intra‐abdominal fat. However, older individuals with comparable weight changes had relatively greater accumulation of fat within the intra‐abdominal and subcutaneous abdominal depots, showing that a smaller degree of weight gain at older ages might still result in adverse metabolic consequences similar to those seen in younger individuals. No effect of sex on changes in either bodyweight or fat was observed. Thus, it appeared that efforts aimed at preventing weight gain might best be directed towards younger age groups in order to reduce overall fat mass and especially visceral fat mass.

In addition to the relationship of age to intra‐abdominal fat accumulation, we have found baseline plasma leptin levels to be positively correlated over 5‐ and 10‐years follow up with change in bodyweight, BMI, total fat (measured by CT), and intra‐abdominal fat in non‐diabetic Japanese American men and women, suggesting that fat accumulation is preceded by increased leptin levels and thus might be associated with leptin resistance[^48,49^](#b48 b49){ref-type="ref"}. Furthermore, elevated baseline plasma leptin levels were shown to be associated with an increased risk of developing diabetes in Japanese American men, but not in women[^50^](#b50){ref-type="ref"}. An additional risk factor for the development of central adiposity in men is low serum testosterone[^51^](#b51){ref-type="ref"}. At 7.5‐years follow up of non‐diabetic Japanese American men, baseline total testosterone (measured at 2.5 years of follow up, 'baseline' for this analysis) was significantly and negatively correlated with increase in intra‐abdominal fat area, but not with BMI, total fat or subcutaneous fat[^52^](#b52){ref-type="ref"}.

Although measurement of visceral adipose fat is clearly the gold standard for estimating obesity‐related disease risk in Japanese Americans, this measurement is not clinically practical. In contrast, waist circumference can be easily measured in a clinical?setting. Two of the most widely used sets of diagnostic criteria for the metabolic syndrome include waist circumference (≥102 cm for men and ≥88 cm for women) as being essential[^53,54^](#b53 b54){ref-type="ref"}. However, very few Japanese Americans meet these waist guidelines[^55^](#b55){ref-type="ref"}. Because of this, we examined cross‐sectionally in Japanese Americans which waist circumference cut‐points (measured at the level of the umbilicus) had the strongest associations with at least two of the non‐adipose components of the metabolic syndrome as defined by the International Diabetes Federation[^56^](#b56){ref-type="ref"}. Using receiver--operating characteristic (ROC) curves, the values that resulted in maximizing the Youden index were defined as 'optimal'[^57,58^](#b57 b58){ref-type="ref"}. Optimal waist circumference cut‐points were found to be 84.5 cm for women and 90.0 cm for men. The optimal waist circumference for women, but not for men, was slightly different from the recommended waist circumference cut‐points for Asians (80 cm for women and 90 cm for men)[^59^](#b59){ref-type="ref"}. We also examined BMI and visceral adiposity measured by CT. The optimal cut‐points for BMI were 23.3 kg/m^2^ for women and 25.3 kg/m^2^ for men, whereas those for intra‐abdominal fat area were 74.9 cm^2^ for women and 96.1 cm^2^ for men. These data are shown in [Table 4](#t4){ref-type="table-wrap"}. Intra‐abdominal fat area was better than either waist circumference or BMI in identifying Japanese Americans at risk for the metabolic syndrome. It should be noted, however, that the measurements of central adiposity were age‐dependent, particularly so in women. When stratified by median age, women aged ≤56 years had optimal cut‐points of 80.8 cm for waist circumference and 51.5 cm^2^ for intra‐abdominal fat area, whereas for women aged \>56 years, the respective values were 89.0 cm and 86.3 cm^2^. These measurements were not so age‐dependent in men ([Table 5](#t5){ref-type="table-wrap"}). Thus age‐specific optimal cut‐points for waist circumference and intra‐abdominal fat area should be considered for women.

######  Optimal cut‐points for intra‐abdominal fat area, waist and body mass index in men and women

          Variable                   Value        Sensitivity (%)   Specificity (%)
  ------- -------------------------- ------------ ----------------- -----------------
  Men     Intra‐abdominal fat area   96.1 cm^2^   70.3              76.5
  Waist   90.0 cm                    55.2         75.8              
  BMI     25.3 kg/m^2^               60.4         71.2              
  Women   Intra‐abdominal fat area   74.9 cm^2^   74.2              75.4
  Waist   84.5 cm                    68.6         67.3              
  BMI     23.3 kg/m^2^               60.5         70.2              

BMI, body mass index.

######  Optimal cut‐points for intra‐abdominal fat area and waist in men and women, stratified by median age

                              ≤57 years‐of‐age   \>57 years‐of‐age
  --------------------------- ------------------ -------------------
  Men                                            
   Intra‐abdominal fat area   88.6 cm^2^         96.1 cm^2^
   Waist                      90.0 cm            87.1 cm
                              ≤56 years‐of‐age   \>56 years‐of‐age
  Women                                          
   Intra‐abdominal fat area   51.5 cm^2^         86.3 cm^2^
   Waist                      80.8 cm            89.0 cm

Insulin Resistance and β‐Cell Dysfunction in Diabetes Pathogenesis {#ss5}
==================================================================

Insulin resistance is associated with obesity and with type 2 diabetes. Reaven proposed insulin resistance to be the primary abnormality in the development of type 2 diabetes[^60^](#b60){ref-type="ref"}. However, not all obese individuals are diabetic, probably because some of these individuals have adequate β‐cell function to compensate for their insulin resistance. This is exemplified by the hyperbolic relationship between insulin sensitivity and insulin secretion[^61^](#b61){ref-type="ref"}.

Porte considered islet dysfunction as playing the pivotal role in the pathogenesis of type 2 diabetes, with frequent contribution from insulin resistance[^62^](#b62){ref-type="ref"}. Among Japanese Americans without diabetes at baseline, the product of OGTT‐derived measures of insulin response and insulin sensitivity, referred to as the oral disposition index, was calculated to assess β‐cell function[^63^](#b63){ref-type="ref"}. This approach, utilizing the previously shown relationship between insulin sensitivity and insulin response, but using information for insulin sensitivity and insulin response that can be derived from an OGTT, delineated differences in the ability of the β‐cell to compensate for insulin resistance between oral glucose tolerance categories in Japanese Americans.

Clearly, there are persons with type 2 diabetes who are not obese and thus are presumably not very insulin resistant. Based on the relationship between insulin sensitivity and β‐cell function, such individuals develop hyperglycemia because they have more profound β‐cell dysfunction than equally hyperglycemic diabetic persons who are obese. This might explain the appearance of diabetes in native Japanese who are not as heavy as Japanese Americans. In addition, however, the balance between β‐cell dysfunction and insulin resistance in the pathogenesis of hyperglycemia might be somewhat different in Asians. We have proposed that Asian Americans who develop diabetes are a group in whom insulin resistance has been superimposed on a genetically determined reduced β‐cell reserve[^64^](#b64){ref-type="ref"}. Japanese data?have shown that in individuals with normal fasting glucose, β‐cells begin to show deteriorating function during normoglycemia with a minimal elevation in fasting glucose. However, there are also glucose‐tolerant Japanese with considerable β‐cell dysfunction who presumably are normoglycemic, because they retain insulin sensitivity[^65^](#b65){ref-type="ref"}. In another study of Japanese patients with normal fasting glucose and glycosylated hemoglobin levels, insulin secretory reserve was shown to be insufficient to compensate for increased insulin resistance[^66^](#b66){ref-type="ref"}. In the past, it has been suggested that most cases of type 2 diabetes in the Japanese population were primarily a result of diminished β‐cell function; whereas in a much smaller group, especially in the obese, there was a significant contribution from insulin resistance[^67^](#b67){ref-type="ref"}. These studies in aggregate support the hypothesis that Japanese might have diminished β‐cell reserve and thus might be susceptible to even small decreases in insulin sensitivity. An analysis of β‐cell function and insulin sensitivity among four ethnic groups in the USA, including Asians, also supports this hypothesis[^68^](#b68){ref-type="ref"}.

The β‐cell abnormalities associated with diabetes fall into two main categories: altered stimulus‐secretion coupling of glucose as an insulin secretagogue and abnormal processing of secretory proteins. As an example of the former, Japanese Americans with abnormal glucose tolerance -- either IGT or diabetes -- have a later peak of insulin during an OGTT than those with NGT[^17,37,69^](#b17 b37 b69){ref-type="ref"}. This delay was also a baseline risk factor for incident diabetes at 5 years in non‐diabetic Japanese Americans[^70^](#b70){ref-type="ref"}. Notably, this group of incident cases at 5 years, although having delayed secretion of insulin after oral glucose, did not have any increase of either fasting insulin or intra‐abdominal fat at baseline, suggesting that the defect in insulin secretion might precede the development of visceral adiposity and insulin resistance during the development of type 2 diabetes. Another product of β‐cells that is co‐secreted with insulin is islet amyloid polypeptide, secretion of which is also reduced in type 2 diabetes. We found decreased secretion of islet amyloid polypeptide in Japanese Americans with either IGT or diabetes[^71^](#b71){ref-type="ref"}.

An example of abnormal secretory protein processing is shown by disproportionately higher circulating proinsulin levels in type 2 diabetes, showing incomplete processing of proinsulin to insulin[^72^](#b72){ref-type="ref"}. The concentration of proinsulin as a percentage of total immunoreactive insulin was higher in Japanese Americans with diabetes compared with those with NGT[^73^](#b73){ref-type="ref"}. Furthermore, baseline proinsulin was higher in non‐diabetic Japanese American men who developed diabetes during 5 years of follow up than in those who remained non‐diabetic[^74^](#b74){ref-type="ref"}. This was not attributable to over‐representation of IGT among those who developed diabetes, as men with IGT were not significantly different from NGT men. This is not surprising, as many individuals with IGT will not develop diabetes over 5 years of follow up. The magnitude of the relative proinsulinemia observed at baseline in those men who progressed to diabetes was less than observed in diabetic individuals, probably because β‐cell function is much more abnormal in the latter.

Genetic Susceptibility {#ss6}
======================

The possibility has been raised that Japanese might be more genetically susceptible to insulin resistance and diabetes than Caucasians. Because of the importance of obesity, insulin resistance and β‐cell dysfunction in the pathophysiology of type 2 diabetes in Japanese Americans, we have examined the β~3~‐adrenergic receptor (Trp64Arg variant of its gene), thought to be involved in thermogenesis and lipolysis in humans; the peroxisome proliferator‐activated receptor γ (PPARγ2 gene), a transcription factor that plays an important role in adipocyte differentiation and expression of adipocyte‐specific genes; and glucokinase (GCK gene promoter), which plays an important role in glucose‐stimulated insulin secretion.

The Trp64Arg variant of the β~3~‐adrenergic receptor had been reported to be associated with higher fasting and 2‐h insulin levels, and HOMA‐IR in Japanese American men with IGT, but not with either NGT or diabetes in Hawaii[^75^](#b75){ref-type="ref"}. We found that this variant was associated with abnormal glucose tolerance, but not with fasting insulin or body fat distribution in Japanese Americans[^76^](#b76){ref-type="ref"}.

Considering PPARγ2, we reported that a Pro12Ala substitution in PPARγ2 was associated with lower BMI and improved insulin sensitivity among middle‐aged and elderly Finns, whereas a *Pro*/*Pro* genotype was found to be associated with type 2 diabetes among Japanese Americans[^77^](#b77){ref-type="ref"}. In addition, we found that there was a trend for individuals with the *Ala* allele to have lower fasting insulin and BMI in each of the three glucose tolerance groups (NGT, IGT and diabetes)[^77^](#b77){ref-type="ref"}. We found the frequency of the *Pro* allele to be significantly higher in Japanese Americans with diabetes than those with NGT, but this difference was not observed in native Japanese[^78^](#b78){ref-type="ref"}. Diabetic Japanese Americans with the *Pro*/*Pro* genotype had significantly higher BMI and fasting insulin than diabetic native Japanese, but when the *Ala*/*Ala* genotype was present, this difference was not found. We postulated that lifestyle might modulate the effects of the *Pro*/*Pro* genotype of the PPARγ2 gene to increase bodyweight and insulin resistance, and thus increase the risk for type 2 diabetes.

We identified six variants of the GCK gene in Japanese Americans who had one or more first‐degree relatives with a history of type 2 diabetes[^79^](#b79){ref-type="ref"}. The only variant that could possibly be associated with abnormal glucose tolerance was the variant at nucleotide −30 in the β‐cell specific promoter. This G→A polymorphism was examined in non‐diabetic Nisei men and was found to be present more frequently in those with IGT than in those with NGT, and was significantly associated with a lower value for the ratio of incremental plasma insulin response above basal at 30 min after oral glucose divided by incremental glucose[^80^](#b80){ref-type="ref"}. When this ratio was divided by the fasting plasma insulin, used as a surrogate for insulin sensitivity, the resulting 'relative insulin response' was also significantly lower in those with the G→A polymorphism. Thus, the −30 β‐cell GCK gene promoter is associated with reduced β‐cell function and might contribute to the high risk of abnormal glucose tolerance in Japanese Americans.

It should be noted that several genome‐wide association studies in Japanese populations have shown an association with diabetes of polymorphisms in the transcription factor 7‐like gene, TCF7L2, and of variants in KCNQ1, the potassium voltage‐gated channel, subfamily Q, member 1 gene[^81--83^](#b81 b82 b83){ref-type="ref"}. Most of the diabetes‐related gene variants in Japanese populations seem to be associated with β‐cell dysfunction.

Prevention {#ss7}
==========

Although glucose‐lowering treatment prevents or ameliorates many of the complications associated with type 2 diabetes, the diagnosis might not be made until complications have already developed. Thus, it might be preferable to direct attention to the prevention of this disease. Our observational research had shown that lifestyle (increased dietary saturated fat and low physical activity) appeared to be closely related to the development of type 2 diabetes in Japanese Americans. Therefore, a lifestyle intervention directed towards reducing dietary saturated fat and increasing physical activity was selected for a pilot study intended to examine whether this combination improved factors associated with type 2 diabetes in Japanese Americans who were at increased risk of developing this disease.

Subsequent to our beginning the present study, the feasibility of preventing or delaying type 2 diabetes through lifestyle change (diet and exercise) was shown by clinical trials in China[^84^](#b84){ref-type="ref"}, Finland[^85^](#b85){ref-type="ref"} and the USA[^86^](#b86){ref-type="ref"}.

Although the measurement of fasting glucose is clinically more practical than an OGTT, we had shown that nearly 40% of 503 Japanese Americans with normal fasting glucose had abnormal glucose tolerance based on oral glucose testing (176 IGT, 20 diabetes)[^87^](#b87){ref-type="ref"}. These individuals with abnormal glucose tolerance had more intra‐abdominal fat and total adiposity; higher fasting insulin, C‐peptide and triglyceride levels; lower HDL cholesterol levels; and higher blood pressure than those with NGT. Thus, classification by fasting glucose alone misses many Japanese Americans with less favorable cardiovascular risk profiles. Most importantly from the viewpoint of diabetes prevention, fasting glucose screening misses many Japanese Americans with IGT and even some with diabetes. Furthermore, the 2‐h glucose surpassed a clinical model (age, sex, ethnicity, BMI, systolic blood pressure, fasting plasma glucose, HDL cholesterol and family history of diabetes) reported to have been useful in predicting diabetes risk in Mexican Americans and non‐Hispanic white participants in the San Antonio Heart Study[^88,89^](#b88 b89){ref-type="ref"}. Hence, in Japanese Americans, the OGTT appeared to be essential in identifying persons at risk for development of type 2 diabetes.

We randomized 64 Japanese American men and women with IGT (from two separate OGTT) to 24 months of either an intervention consisting of an American Heart Association (AHA) step 2 diet (\<30% of total calories as fat, \<7% saturated fat, 55% carbohydrate and \<200 mg cholesterol daily) plus endurance exercise for 1 h three times a week, or a control regimen of an AHA step 1 diet (30% of total calories as fat, 10% saturated fat, 50% carbohydrate and \<300 mg cholesterol daily) plus stretching exercise three times a week[^90^](#b90){ref-type="ref"}. Participants were supervised closely during the first 6 months, whereas for the subsequent 18 months, they were instructed to continue with their prescribed program. Measurements included BMI, body composition (% fat) assessed by underwater weighing, body fat distribution by CT and skinfolds, and insulin secretion and sensitivity (*S*~i~) by an insulin‐modified, frequently sampled, intravenous glucose tolerance test (FSIGTT) at baseline and at 6 and 24 months of follow up. A 75‐g OGTT was carried out at baseline, and at 6, 12 and 24 months of follow up. Intervention resulted in significant reduction at 6 and 24 months of overall adiposity as measured by bodyweight, BMI and underwater weighing ([Figure 6](#f6){ref-type="fig"}). Body fat distribution, including intra‐abdominal fat, was also improved. Intervention also improved insulin sensitivity, but not β‐cell function ([Figure 7](#f7){ref-type="fig"}). The proportion of participants showing NGT at least once during their 24 months of follow up was significantly greater in the intervention group (67% vs 30%, *P* = 0.01). The incremental glucose area during the OGTT as a measure of glucose tolerance was significantly lower in the intervention group at 6 months (*P* = 0.03) and showed a trend towards being lower at 18 months (*P* = 0.08). In linear regression models, the changes from baseline to 24 months for weight, percent body fat, and intra‐abdominal and subcutaneous fat areas were significantly associated with *S*~i~. In multiple linear regression models, the change in intra‐abdominal fat area was independently associated with *S*~i~ after adjusting for change in subcutaneous fat area, whereas the latter was not independently associated with *S*~i~ after adjusting for change in intra‐abdominal fat area[^91^](#b91){ref-type="ref"}. These results suggest that lifestyle modification comprised of dietary saturated fat reduction and aerobic exercise reduces factors associated with diabetes risk, and therefore might delay or prevent type 2 diabetes in Japanese Americans with IGT.

![ Lifestyle intervention significantly reduced overall adiposity as measured by (a) bodyweight and (b) underwater weighing at 6 and 24 months compared with control. Lifestyle intervention also significantly reduced (c) intra‐abdominal fat (IAF) area at 6 and 24 months and (d) waist circumference at 24 months compared with control. *P*‐values for control vs intervention group comparisons are shown above the bars.](jdi-3-212-g6){#f6}

![ Lifestyle intervention significantly improved (a) insulin sensitivity at 6 and 24 months compared with control, but had no effect upon (b) beta‐cell function. *P*‐values for control vs intervention group comparisons are shown above the bars. AIRg, acute insulin response to glucose.](jdi-3-212-g7){#f7}

Recently, the results of an unmasked, multicenter, randomized, controlled trial of 641 overweight (mean BMI 27.0 kg/m^2^) native Japanese men and women with IFG have been reported from Japan[^92^](#b92){ref-type="ref"}. Participants with IFG were tested by OGTT to exclude individuals with diabetes. Those remaining eligible were randomly assigned to a frequent intervention group or a control group. The intervention was the same for both groups (reduce total energy intake, taking into consideration Japan Diabetes Society recommendations for diabetic patients, increase physical activity, with a goal of a 5% reduction in bodyweight), but the frequency of support from study staff differed. The frequent intervention group received support from study staff at least nine times and as much as 11 times over 36 months, whereas the control group received much less frequent contact (four times over 36 months). There was a significant reduction in the cumulative incidence of type 2 diabetes in the frequent intervention group (12.2% vs 16.6%). Notably, this reduction was found in those participants who had IGT at baseline and was not observed in those with isolated impaired fasting glucose.

Thus, it appears that the risk of developing obesity‐related diseases, such as type 2 diabetes, might be reduced by imposition of lifestyle modification among both Japanese Americans and native Japanese.

Conclusions {#ss8}
===========

Many epidemiological studies have shown associations between outcomes and risk factors that suggest cause and effect. The Seattle Japanese American Community Diabetes Study was planned to be a metabolically based epidemiological study with extensive measurements related to glucose metabolism, overall adiposity and body fat distribution, including serial CT measurements. The result is a clearer understanding of the etiology and pathogenesis of diabetes in Japanese Americans that might be applicable to many other populations of Asian origin. To prove the latter, prospective studies and clinical trials are necessary. In addition, to learn more about how hyperglycemia develops, these studies should include appropriate measurements of insulin sensitivity, insulin response, and adiposity, including body fat distribution. However, because of the expense that can be associated with such measurements, the research design will necessarily include a smaller number of study participants than classical epidemiologic research, which often includes hundreds or even thousands of individuals. Such an approach could even be expanded to provide the opportunity to determine how the pathogenesis of diabetes in Asians compares to that in other population groups.

It is not possible to modify one's genetic background, so the approach to reverse the current epidemic of diabetes in Asian populations is to change lifestyle. A desirable outcome of the latter would be to reduce the development of 'metabolic obesity'; that is, body fat accumulation that increases the risk of obesity‐related diseases. We have shown that this is feasible. Lifestyle changes can be applied broadly on a population basis, or can be directed to individuals who are judged to be at increased genetic risk for diabetes as ascertained by information, such as a family history of diabetes. Metabolic and genetic profiling might become a tool in the future to identify those individuals who have increased metabolic susceptibility to diabetes and to direct therapies that appropriately address the identified metabolic abnormalities.

In conclusion, a possible scenario for the 'saga of Japanese in America', that is, the history of the emigration of Japanese to the USA and the changes that have occurred in the population, is that a lifestyle transition has occurred. The pretransition lifestyle favored individuals who were able to efficiently store available food preferentially in a metabolically active visceral adipose compartment that allowed pancreatic islet β‐cell reserve to be low without detrimental consequence. The post‐transition lifestyle in which efficient fat storage was no longer essential might have caused visceral adiposity and insulin resistance to develop. This interaction of 'nature' and 'nurture' in turn brought out the shortcomings of a reduced β‐cell reserve, resulting in glucose intolerance and diabetes. The lesson is that if insulin resistance is prevented, it should be possible to prevent or delay progression to diabetes in this population.
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